Production Planner at Bristol-Myers Squibb

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Entry Level & New GradExperience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, RadiopharmaceuticalsIndustries

Requirements

Bachelor's degree in a related field (e.g., Supply Chain Management, Business Administration, or a scientific discipline) is preferred
Planning or order management experience a bonus
Pharmaceutical industry experience is a bonus
Strong organizational and analytical skills
Concise communication skills and ability to work with people at all levels of the organization
Excellent attention to detail and the ability to manage multiple tasks simultaneously
Love for complex systems
Ability to work independently with agile problem-solving

Responsibilities

Monitor dose order form submission
Create and submit manufacturing orders
Collaborate with cross-functional teams to ensure seamless production and delivery of radiopharmaceuticals
Ensure the timely processing of calibration sample orders by working closely with Radiochemistry and Logistics teams
Monitor and track RAM (Radioactive Material) license status, ensuring adherence to regulatory requirements
Oversee supply chain management for Radioactive drug, including production capabilities, and coordination with Quality and Logistics teams
Maintain comprehensive records and documentation for all orders and processes, ensuring accuracy and compliance
Implement project management tools and best practices for tracking progress, reporting, and documentation

Skills

Production Planning

Supply Chain Management

Analytical Skills

Problem-Solving

Multitasking

Administrative Management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free